glp 1 parkinson's disease and neuroprotection Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's Diseases | CNS Drugs Antidiabetic medications modify metabolic, inflammatory,

More promising results, however, were announced the same month by Eli Lilly for its new once-daily GLP-1 pill which showed promise for weight management and for the treatment of type-2 diabetes

I Answered Retatrutide's Biggest Unanswered Questions Retatrutide could become the biggest drug in history

While cortisol is necessary in short bursts for "fight or flight" responses, consistently high levels can wreak havoc on your metabolism and contribute to weight gain, particularly around the abdomen

105 NeoviusM.SundstromJ.RasmussenF

D.GloverL

My Approach When Prescribing Here's my general framework not a rigid protocol, but a starting point for the conversation: I Tend to Start with Semaglutide When The patient has established cardiovascular disease (because of the SELECT trial data) Insurance covers semaglutide but not tirzepatide The patient has MASH/fatty liver disease Cost is the primary concern and semaglutide is more accessible I Tend to Start with Tirzepatide When Maximum weight loss is the primary goal The patient has type 2 diabetes (tirzepatide shows greater A1C reduction roughly 2.02.5% vs 1.02.0% for semaglutide) The patient has tried semaglutide with insufficient results Insurance covers both options equally Regardless of which medication we choose, I always emphasize that GLP-1 therapy is most effective when combined with nutritional counseling, physical activity, and behavioral support